Evidence map›Paper›PMID 21390190›Full record

ArticleNeoplasia (New York, N.Y.)2011

Imaging bone morphogenetic protein 7 induced cell cycle arrest in experimental gliomas.

Anke Klose, Yannic Waerzeggers, Parisa Monfared, Slobodan Vukicevic, Eric L Kaijzel, Alexandra Winkeler, Claudia Wickenhauser, Clemens W G M Löwik, Andreas H Jacobs

Open access · goldAbstract read
In one paragraph

Article in Neoplasia (New York, N.Y.), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. The Role of Neurodevelopmental Pathways in Brain Tumors.Frontiers in cell and developmental biology · 2021
    Review
  7. Multi-Omics Analysis Reveals the Pan-Cancer Landscape of Bone Morphogenetic Proteins.Medical science monitor : international medical journal of experimental and clinical research · 2020
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Anke KloseEuropean Institute for Molecular Imaging, University of Münster, Germany.
Yannic Waerzeggers
Parisa Monfared
Slobodan Vukicevic
Eric L Kaijzel
Alexandra Winkeler
Claudia Wickenhauser
Clemens W G M Löwik
Andreas H Jacobs
University of Münster · DELeipzig University · DELeiden University Medical Center · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bone morphogenetic protein 7 (BMP-7) belongs to the superfamily of transforming growth factor β-like cytokines, which can act either as tumor suppressors or as tumor promoters depending on cell type and differentiation. Our investigations focused on analyzing the effects of BMP-7 during glioma cell proliferation in vitro and in vivo. BMP-7 treatment decreased the proliferation of Gli36ΔEGFR-LITG glioma cells up to 50%through a cell cycle arrest in the G(1) phase but not by induction of apoptosis. This effect was mediated by the modulation of the expression and phosphorylation of cyclin-dependent kinase 2, cyclin-dependent kinase inhibitor p21, and downstream retinoblastoma protein. Furthermore, in vivo optical imaging of luciferase activity of Gli36ΔEGFR-LITG cells implanted intracranially into nude mice in the presence or absence of BMP-7 treatment corroborated the antiproliferative effects of this cytokine. This report clearly underlines the tumor-suppressive role of BMP-7 in glioma-derived cells. Taken together, our results indicate that manipulating the BMP/transforming growth factor β signaling cascade may serve as a new strategy for imaging-guided molecular-targeted therapy of malignant gliomas.

Indexed as

Cell ProliferationG1 PhaseAnimalsBlotting, WesternBone Morphogenetic Protein 7Cell DifferentiationCyclin-Dependent Kinase 2Cyclin-Dependent Kinase Inhibitor p21Fluorescent Antibody TechniqueGliomaLuciferasesLuminescenceMiceMice, Inbred BALB CMolecular Targeted TherapyPhosphorylationBone Morphogenetic Protein 7Cyclin-Dependent Kinase 2Cyclin-Dependent Kinase Inhibitor p21LuciferasesRetinoblastoma ProteinRNA, MessengerTransforming Growth Factor beta

Identifiers

PMID21390190
PMCPMC3050870
OpenAlexW1786246680

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.